US › Healthcare

Connect Biopharma Holdings Ltd (CNTB)

US · Healthcare · Biotechnology

$0.91+0.01%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.9M

Revenue YoY

+6018.8%

Net profit

$-36.7M

EPS

$-0.27

EPS estimate

$-0.32

Net margin

-1,249.0%

EPS came in at -0.27 against a street estimate of -0.32 — a beat of 15.6%.

Key statistics

Market cap

$57.1M

Forward P/E

0.8

P/B

2.50

Book value

$0.43

EPS (TTM)

$-1.16

52-week high

$3.82

52-week low

$0.85

50-day MA

$1.72

200-day MA

$2.29

Beta

-0.18

Analyst view

Analysts rate Connect Biopharma Holdings Ltd a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $5.88.

Shareholding

Insiders

30.34%

Institutions

61.36%

Largest institutional holders

Fund	Stake
Quadrature Capital Limited	0.07%
EverSource Wealth Advisors, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Connect Biopharma Holdings Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.